James M. Gower
2007
In 2007, James M. Gower earned a total compensation of $1.8M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 27% decrease compared to previous year.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Non-Equity Incentive Plan | $300,000 |
| Option Awards | $716,060 |
| Salary | $500,000 |
| Other | $2,412 |
| Total | $1,818,472 |
Gower received $716.1K in option awards, accounting for 39% of the total pay in 2007.
Gower also received $300K in bonus, $300K in non-equity incentive plan, $500K in salary and $2.4K in other compensation.
Rankings
In 2007, James M. Gower's compensation ranked 2,543rd out of 8,700 executives tracked by ExecPay. In other words, Gower earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,543 out of 8,700 | 71st |
Division Manufacturing | 867 out of 3,314 | 74th |
Major group Chemicals And Allied Products | 164 out of 746 | 78th |
Industry group Drugs | 88 out of 546 | 84th |
Industry Pharmaceutical Preparations | 68 out of 364 | 81st |
Source: SEC filing on April 12, 2010.
Gower's colleagues
We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2007.
2007
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2007
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2007
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2007
Ryan Maynard
Rigel Pharmaceuticals